title: RNA interference inhibits yellow fever virus replication in vitro and in vivo.
abstract: RNA interference (RNAi) is a process that is induced by double stranded RNA and involves the degradation of specific sequences of mRNA in the cytoplasm of the eukaryotic cells. It has been used as an antiviral tool against many viruses, including flaviviruses. The genus Flavivirus contains the most important arboviruses in the world, i.e., dengue (DENV) and yellow fever (YFV). In our study, we investigated the in vitro and in vivo effect of RNAi against YFV. Using stable cell lines that expressed RNAi against YFV, the cell lines were able to inhibit as much as 97% of the viral replication. Two constructions (one against NS1 and the other against E region of YFV genome) were able to protect the adult Balb/c mice against YFV challenge. The histopathologic analysis demonstrated an important protection of the central nervous system by RNAi after 10 days of viral challenge. Our data suggests that RNAi is a potential viable therapeutic weapon against yellow fever.
authors.affiliation: Laboratório de Pesquisas em Virologia, Departamento de Doenças Dermatológicas, Infecciosas e Parasitárias, Faculdade de Medicina de São José do Rio Preto-FAMERP, Av. Brigadeiro Faria Lima 5416, São José do Rio Preto, SP, 15090-000, Brazil.
authors.forename: Carolina C
authors.initials: CC
authors.lastname: Pacca
authors.forename: Adriana A
authors.initials: AA
authors.lastname: Severino
authors.forename: Adriano
authors.initials: A
authors.lastname: Mondini
authors.forename: Paula
authors.initials: P
authors.lastname: Rahal
authors.forename: Solange G P
authors.initials: SG
authors.lastname: D'avila
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Cordeiro
authors.forename: Mara Correa Lelles
authors.initials: MC
authors.lastname: Nogueira
authors.forename: Roberta V M
authors.initials: RV
authors.lastname: Bronzoni
authors.forename: Maurício L
authors.initials: ML
authors.lastname: Nogueira
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002490:Central Nervous System / Q000473:pathology; D002522:Chlorocebus aethiops; D051379:Mice; D008807:Mice, Inbred BALB C; D034622:RNA Interference; D034741:RNA, Small Interfering / Q000494:pharmacology / Q000627:therapeutic use*; D016019:Survival Analysis; D014709:Vero Cells; D014759:Viral Envelope Proteins / Q000037:antagonists & inhibitors / Q000235:genetics; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors / Q000235:genetics; D014779:Virus Replication; D015004:Yellow Fever / Q000188:drug therapy* / Q000473:pathology; D015005:Yellow fever virus / Q000187:drug effects* / Q000235:genetics / Q000502:physiology*
chemical_list: D000998:Antiviral Agents; C100315:NS1 protein, Flavivirus; D034741:RNA, Small Interfering; D014759:Viral Envelope Proteins; D017361:Viral Nonstructural Proteins; C078400:yellow fever virus envelope protein E